Steven Rubin

Insider Reports History

Location
Miami, FL
Signature
/s/ Steven Rubin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven Rubin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Red Violet, Inc. Director Common Stock 145,588 $8,650,838 $59.42 19 Dec 2025 Direct
OPKO HEALTH, INC. Executive VP-Administration, Director Common Stock 6,625,232 $8,380,918 $1.26 24 Jul 2024 Direct
Eloxx Pharmaceuticals, Inc. Director Restricted Stock Units 3,750 $5,400 $0.7200 24 Jan 2025 Direct
OPKO HEALTH, INC. Executive VP-Administration, Director Stock Option (Right to Buy) 437,500 27 May 2025 Direct
Niagen Bioscience, Inc. Director Stock Option (right to buy) 20,000 24 Jun 2025 Direct
Cocrystal Pharma, Inc. Director Stock Options (Right to Buy) 16,410 09 Jan 2026 Direct
Eloxx Pharmaceuticals, Inc. Director Common Stock 15,750 24 Jan 2025 Direct

Insider Reports Filed by Steven Rubin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
COCP Cocrystal Pharma, Inc. 09 Jan 2026 1 $0 4 Director 13 Jan 2026, 16:10
RDVT Red Violet, Inc. 19 Dec 2025 1 $0 4 Director 22 Dec 2025, 18:52
NAGE Niagen Bioscience, Inc. 24 Jun 2025 1 $0 4 Director 25 Jun 2025, 20:29
OPK OPKO HEALTH, INC. 27 May 2025 1 $0 4 Executive VP-Administration, Director 29 May 2025, 17:04
RDVT Red Violet, Inc. 19 Mar 2025 1 -$389,300 4 Director 21 Mar 2025, 18:30
/report/000110465925006783-rubin-steven-d-2025-01-24 Eloxx Pharmaceuticals, Inc. 24 Jan 2025 2 $0 4 Director 28 Jan 2025, 17:36
RDVT Red Violet, Inc. 04 Nov 2024 1 $0 4 Director 05 Nov 2024, 18:53
/report/000110465924109523-rubin-steven-d-2024-10-16 Eloxx Pharmaceuticals, Inc. 16 Oct 2024 1 $0 4 Director 17 Oct 2024, 16:01
COCP Cocrystal Pharma, Inc. 09 Oct 2024 1 $0 4 Director 11 Oct 2024, 16:05
OPK OPKO HEALTH, INC. 24 Jul 2024 1 $0 4 Executive VP-Administration, Director 26 Jul 2024, 19:11
NAGE ChromaDex Corp. 20 Jun 2024 1 $0 4 Director 24 Jun 2024, 17:45
/report/000110465924007293-rubin-steven-d-2024-01-24 Eloxx Pharmaceuticals, Inc. 24 Jan 2024 1 $0 4 Director 26 Jan 2024, 16:33
OPK OPKO HEALTH, INC. 05 Jan 2024 1 +$8,669 4 Executive VP-Administration, Director 05 Jan 2024, 13:39
RDVT Red Violet, Inc. 30 Nov 2023 1 $0 4 Director 04 Dec 2023, 18:30
OPK OPKO HEALTH, INC. 10 Nov 2023 1 +$13,000 4 Executive VP-Administration, Director 13 Nov 2023, 08:21
COCP Cocrystal Pharma, Inc. 18 Jul 2023 1 $0 4 Director 20 Jul 2023, 16:05
NAGE ChromaDex Corp. 15 Jun 2023 1 $0 4 Director 16 Jun 2023, 17:28
NAGE ChromaDex Corp. 25 May 2023 1 +$10,220 4 Director 30 May 2023, 16:13
OPK OPKO HEALTH, INC. 18 May 2023 1 $0 4 Executive VP-Administration, Director 19 May 2023, 16:37
/report/000110465923008601-rubin-steven-d-2023-01-30 Eloxx Pharmaceuticals, Inc. 30 Jan 2023 1 $0 4 Director 31 Jan 2023, 15:09
RDVT Red Violet, Inc. 12 Oct 2022 1 $0 4 Director 13 Oct 2022, 18:56
COCP Cocrystal Pharma, Inc. 25 Jul 2022 1 $0 4 Director 03 Aug 2022, 16:02
NAGE ChromaDex Corp. 16 Jun 2022 1 $0 4 Director 21 Jun 2022, 19:10
/report/000110465922072187-rubin-steven-d-2022-06-15 Eloxx Pharmaceuticals, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 08:27
RDVT Red Violet, Inc. 24 Sep 2021 1 $0 4 Director 27 Sep 2021, 18:30
COCP Cocrystal Pharma, Inc. 16 Jul 2021 1 $0 4 Director 20 Jul 2021, 16:05
NAGE ChromaDex Corp. 17 Jun 2021 1 $0 4 Director 22 Jun 2021, 17:27
/report/000141588921002609-rubin-steven-d-2021-05-19 Eloxx Pharmaceuticals, Inc. 19 May 2021 1 $0 4 Director 20 May 2021, 16:10